Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Inflammatory bowel disease and preterm delivery.

Wispelwey BP, Sheiner E.

Arch Gynecol Obstet. 2013 Oct;288(4):725-30. doi: 10.1007/s00404-013-2989-3. Epub 2013 Aug 10. Review.

PMID:
23934241
2.

Is safety infliximb during pregnancy in patients with inflammatory bowel disease?

Argüelles-Arias F, Castro-Laria L, Barreiro-de Acosta M, García-Sánchez MV, Guerrero-Jiménez P, Gómez-García MR, Cordero-Ruiz P, Iglesias-Flores E, Gómez-Camacho F, Domínguez-Muñoz EJ, Herrerías-Gutiérrez JM.

Rev Esp Enferm Dig. 2012 Feb;104(2):59-64.

3.

Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes.

Boyd HA, Basit S, Harpsøe MC, Wohlfahrt J, Jess T.

PLoS One. 2015 Jun 17;10(6):e0129567. doi: 10.1371/journal.pone.0129567. eCollection 2015.

4.

Intrapartum corticosteroid use significantly increases the risk of gestational diabetes in women with inflammatory bowel disease.

Leung YP, Kaplan GG, Coward S, Tanyingoh D, Kaplan BJ, Johnston DW, Barkema HW, Ghosh S, Panaccione R, Seow CH; Alberta IBD Consortium; APrON Study Team.

J Crohns Colitis. 2015 Mar;9(3):223-30. doi: 10.1093/ecco-jcc/jjv006. Epub 2015 Jan 9.

PMID:
25576754
5.

Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-α therapy during pregnancy: three-center study.

Bortlik M, Machkova N, Duricova D, Malickova K, Hrdlicka L, Lukas M, Kohout P, Shonova O, Lukas M.

Scand J Gastroenterol. 2013 Aug;48(8):951-8. doi: 10.3109/00365521.2013.812141. Epub 2013 Jul 8.

PMID:
23834232
6.

Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006.

Bortoli A, Pedersen N, Duricova D, D'Inca R, Gionchetti P, Panelli MR, Ardizzone S, Sanroman AL, Gisbert JP, Arena I, Riegler G, Marrollo M, Valpiani D, Corbellini A, Segato S, Castiglione F, Munkholm P; European Crohn-Colitis Organisation (ECCO) Study Group of Epidemiologic Committee (EpiCom).

Aliment Pharmacol Ther. 2011 Oct;34(7):724-34. doi: 10.1111/j.1365-2036.2011.04794.x. Epub 2011 Aug 4. Erratum in: Aliment Pharmacol Ther. 2013 Aug;38(3):328.

7.

Pregnancy outcome in patients with inflammatory bowel disease according to the activity of the disease and the medical treatment: a case-control study.

Molnár T, Farkas K, Nagy F, Lakatos PL, Miheller P, Nyári T, Horváth G, Szepes Z, Marik A, Wittmann T.

Scand J Gastroenterol. 2010 Nov;45(11):1302-6. doi: 10.3109/00365521.2010.503967. Epub 2010 Jul 5.

PMID:
20602569
8.

Anti-TNFα therapies are safe during pregnancy in women with inflammatory bowel disease: a systematic review and meta-analysis.

Narula N, Al-Dabbagh R, Dhillon A, Sands BE, Marshall JK.

Inflamm Bowel Dis. 2014 Oct;20(10):1862-9. doi: 10.1097/MIB.0000000000000092. Review.

PMID:
24983985
9.

[Inflammatory bowel disease and pregnancy].

Parfenov AI.

Eksp Klin Gastroenterol. 2012;(3):80-6. Review. Russian.

PMID:
22830229
10.

Anti-TNF antibody therapy for inflammatory bowel disease during pregnancy: a clinical review.

El Mourabet M, El-Hachem S, Harrison JR, Binion DG.

Curr Drug Targets. 2010 Feb;11(2):234-41. Review.

PMID:
19916950
11.

Pregnancy and inflammatory bowel disease: a prospective case-control study.

Malgarinos G, Gikas A, Delicha E, Stamataki A, Georgopoulos F, Papadimitriou A, Stanciu C, Triantafillidis JK.

Rev Med Chir Soc Med Nat Iasi. 2007 Jul-Sep;111(3):613-9.

PMID:
18293689
12.

Preterm birth in women with inflammatory bowel disease - the association with disease activity and drug treatment.

Bröms G, Granath F, Stephansson O, Kieler H.

Scand J Gastroenterol. 2016 Dec;51(12):1462-1469. Epub 2016 Jul 18.

PMID:
27739352
13.

Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease.

Akbari M, Shah S, Velayos FS, Mahadevan U, Cheifetz AS.

Inflamm Bowel Dis. 2013 Jan;19(1):15-22. doi: 10.1002/ibd.22948. Review.

PMID:
22434610
14.

Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis.

Rahimi R, Nikfar S, Rezaie A, Abdollahi M.

Reprod Toxicol. 2008 Feb;25(2):271-5. doi: 10.1016/j.reprotox.2007.11.010. Epub 2007 Dec 4.

PMID:
18242053
15.

[Inflammatory bowel diseases: gynecological and obstetrical considerations].

Amate P, Seirafi M, Bouhnik Y, Luton D, Ducarme G.

J Gynecol Obstet Biol Reprod (Paris). 2011 Nov;40(7):612-9. doi: 10.1016/j.jgyn.2011.05.010. Epub 2011 Jul 5. Review. French.

16.

[Pregnancy and inflammatory bowel disease: experience in 17 patients].

Vergara A MT, Rey G P.

Rev Med Chil. 2011 Nov;139(11):1421-7. doi: /S0034-98872011001100005. Epub 2012 Feb 8. Spanish.

17.

Effects and treatment of inflammatory bowel disease during pregnancy.

Brar H, Einarson A.

Can Fam Physician. 2008 Jul;54(7):981-3.

18.

Inflammatory bowel disease and pregnancy: overlapping pathways.

Nasef NA, Ferguson LR.

Transl Res. 2012 Jul;160(1):65-83. doi: 10.1016/j.trsl.2011.12.002. Epub 2011 Dec 23. Review.

PMID:
22687963
19.

Review article: a decision-making algorithm for the management of pregnancy in the inflammatory bowel disease patient.

Habal FM, Huang VW.

Aliment Pharmacol Ther. 2012 Mar;35(5):501-15. doi: 10.1111/j.1365-2036.2011.04967.x. Epub 2012 Jan 5. Review.

Supplemental Content

Support Center